Gencove, Inc.
Low-pass whole genome sequencing platform with raw genetic data access
- Sector
- Medtech
- Headquarters
- New York, NY
- Founded
- 2015
- Latest Form D
- $9.8M, Nov 2021
- Total capital
- $15.3M
- Federal grants
- $330K
- 1 award · 2019
- Rank in peer group#80 of 95
- Private capital raised
- $14.9M
- 4 Form D · last Nov 2021
- 60 months since last filing
- Federal contracts
- None on recordNo federal contract awards found.
- Granted patents
- 0
- 2 pending
Capital timeline
Latest events
- Private capital raisedForm D · SEC · 4th filing$9.8M
- Private capital raisedForm D · SEC · 3rd filing$1.4M
- Federal grantHealth and Human S · Phase I · Scalable and accurate polygenic risk profiling with low-pass whole genome sequencing$330K
- Private capital raisedForm D · SEC · 2nd filing$2.7M
- Private capital raisedForm D · SEC · 1st filing$1M
Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.
Standing among 95 peers
Line = medianMedtech · Instrument
- Federal grantsBelow median
Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.
Founders and team
Researcher links verified by same-company patents and grants- Joseph PickrellResearcherExecutive Officer, DirectorLinked by $330K in grants as PI
- Larry PageDirectorNamed in SEC Form D filings
- Sara EshelmanDirectorNamed in SEC Form D filings
- Shripriya MaheshDirectorNamed in SEC Form D filings
- Tomaz BerisaExecutive Officer, DirectorNamed in SEC Form D filings
What it has protected
USPTO · 0 granted of 2- PendingMethods For Joint Low-pass And Targeted SequencingUSPTOApplication 16354575
- PendingMethods For Joint Low-pass And Targeted SequencingUSPTOApplication PCTUS2019022445
Related companies, and why
- Cape Bioresearch, Inc.Similar federal contract value in Medtech · null in contracts
- NANOVA INC.Similar federal contract value in Medtech · null in contracts
- NANOS, INC.Similar federal contract value in Medtech · null in contracts
- ImCare Biotech LLCSimilar federal contract value in Medtech · null in contracts
- Strive Tech Inc.Similar federal contract value in Medtech · null in contracts
- Definitive Biotechnologies LLCSimilar federal contract value in Medtech · null in contracts
Regulatory activity · Medtech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.
Sources
Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.
How to read this page
Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.
Data freshness
SEC Form D filings through . SBIR and STTR awards through .